Endothelial-specific Nox2 overexpression increases vascular superoxide and macrophage recruitment in ApoE -/- mice

Cardiovascular Research

Volumn 94, Issue 1, 2012, Pages 20-29

  Douglas, Gillian ^a   Bendall, Jennifer K ^a   Crabtree, Mark J ^a   Tatham, Amy L ^a   Carter, Emma E ^b   Hale, Ashley B ^a   Channon, Keith M ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Atherosclerosis; Macrophages; NADPH oxidase; Nox2; VCAM 1

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE 2; SUPEROXIDE; VASCULAR CELL ADHESION MOLECULE 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; AORTA ROOT; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; DESCENDING AORTA; ENDOTHELIUM CELL; GENE OVEREXPRESSION; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANGIOTENSIN II; ANIMALS; AORTIC DISEASES; APOLIPOPROTEINS E; ATHEROSCLEROSIS; BLOOD PRESSURE; CHEMOTAXIS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; ENDOTHELIAL CELLS; HUMANS; MACROPHAGES; MEMBRANE GLYCOPROTEINS; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; NADPH OXIDASE; SIGNAL TRANSDUCTION; SUPEROXIDES; TIME FACTORS; UP-REGULATION; VASCULAR CELL ADHESION MOLECULE-1;

EID: 84859082257     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs026     Document Type: Article

References (27)

1. Cai H, Harrison DG. Endothelial dysfunction in cardiovascular diseases: the role of oxidant stress. Circ Res 2000;87:840-844.
2. Cave AC, Brewer AC, Narayanapanicker A, Ray R, Grieve DJ,Walker S et al. NADPH Oxidases in Cardiovascular Health and Disease. Antioxid Redox Signal 2006;8: 691-728.
3. Gorlach A, Brandes RP, Nguyen K, Amidi M, Dehghani F, Busse R. A gp91phox containing NADPH oxidase selectively expressed in endothelial cells is a major source of oxygen radical generation in the arterial wall. Circ Res 2000;87:26-32.
4. Ago T, Kitazono T, Ooboshi H, Iyama T, Han YH, Takada J et al. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase. Circulation 2004;109: 227-233.
5. Lassegue B, Sorescu D, Szocs K, Yin Q, Akers M, Zhang Y et al. Novel gp91(phox) homologues in vascular smooth muscle cells : nox1 mediates angiotensin II-induced superoxide formation and redox-sensitive signaling pathways. Circ Res 2001;88: 888-894.
6. Ellmark SHM, Dusting GJ, Ng Tang Fui M, Guzzo-Pernell N, Drummond GR. The contribution of Nox4 to NADPH oxidase activity in mouse vascular smooth muscle. Cardiovasc Res 2005;65:495-504.
7. Lassegue B, Griendling KK. NADPH oxidases: functions and pathologies in the vasculature. Arterioscler Thromb Vasc Biol 2010;30:653-661.
8. Guzik TJ, Sadowski J, Guzik B, Jopek A, Kapelak B, Przybylowski P et al. Coronary artery superoxide production and Nox isoform expression in human coronary artery disease. Arterioscler Thromb Vasc Biol 2006;26:333-339.
9. Judkins CP, Diep H, Broughton BRS, Mast AE, Hooker EU, Miller AA et al. Direct evidence of a role for Nox2 in superoxide production, reduced nitric oxide bioavailability, and early atherosclerotic plaque formation in ApoE-/- mice. Am J Physiol Heart Circ Physiol 2010;298:H24-H32.
10. Kirk EA, Dinauer MC, Rosen H, Chait A, Heinecke JW, LeBoeuf RC. Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arterioscler Thromb Vasc Biol 2000;20:1529-1535.
11. Hsich E, Segal BH, Pagano PJ, Rey FE, Paigen B, Deleonardis J et al. Vascular effects following homozygous disruption of p47(phox) : an essential component of NADPH oxidase. Circulation 2000;101:1234-1236.
12. Barry-Lane PA, Patterson C, van der Merwe M, Hu Z, Holland SM, Yeh ET et al. p47phox is required for atherosclerotic lesion progression in ApoE(-/-) mice. J Clin Invest 2001;108:1513-1522.
13. Guzik TJ,West NEJ, Black E, McDonald D, Ratnatunga C, Pillai R et al. Vascular superoxide production by NAD(P)H oxidase: association with endothelial dysfunction and clinical risk factors. Circ Res 2000;86:e85-e90.
14. Guzik TJ, Mussa S, Gastaldi D, Sadowski J, Ratnatunga C, Pillai R et al. Mechanisms of increased vascular superoxide production in human diabetes mellitus: Role of NAD(P)H oxidase and endothelial nitric oxide synthase. Circulation 2002;105: 1656-1662.
15. Bendall JK, Rinze R, Adlam D, Tatham AL, de Bono J, Channon KM. Endothelial Nox2 overexpression potentiates vascular oxidative stress and hemodynamic response to angiotensin II: studies in endothelial-targeted Nox2 transgenic mice. Circ Res 2007; 100:1016-1025.
16. Coleman R, Hayek T, Keidar S, Aviram M. A mouse model for human atherosclerosis: long-term histopathological study of lesion development in the aortic arch of apolipoprotein E-deficient (E0) mice. Acta Histochemica 2006;108:415-424.
17. Crabtree MJ, Tatham AL, Al-Wakeel Y, Warrick N, Hale AB, Cai S et al. Quantitative regulation of intracellular endothelial nitric oxide synthase (eNOS) coupling by both tetrahydrobiopterin-eNOS stoichiometry and biopterin redox status: insights from cells with tet-regulated GTP cyclohydrolase I expression. J Biol Chem 2009;284: 1136-1144.
18. Bendall JK, Alp NJ, Warrick N, Cai S, Adlam D, Rockett K et al. Stoichiometric relationships between endothelial tetrahydrobiopterin, eNOS activity and eNOS coupling in vivo: Insights from transgenic mice with endothelial-targeted GTPCH and eNOS over-expression. Circ Res 2005;97:864-871.
19. Dansky HM, Barlow CB, Lominska C, Sikes JL, Kao C, Weinsaft J et al. Adhesion of monocytes to arterial endothelium and initiation of atherosclerosis are critically dependent on vascular cell adhesion molecule-1 gene dosage. Arterioscler Thromb Vasc Biol 2001;21:1662-1667.
20. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R. ApoE-deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb 1994;14:133-140.
21. Sorescu D, Weiss D, Lassegue B, Clempus RE, Szocs K, Sorescu GP et al. Superoxide production and expression of nox family proteins in human atherosclerosis. Circulation 2002;105:1429-1435.
22. Pueyo ME, Gonzalez W, Nicoletti A, Savoie F, Arnal J-F, Michel J-B. Angiotensin II stimulates endothelial vascular cell adhesion molecule-1 via nuclear factor-{kappa}B activation induced by intracellular oxidative stress. Arterioscler Thromb Vasc Biol 2000;20: 645-651.
23. Dikalov SI, Dikalova AE, Bikineyeva AT, Schmidt HHHW, Harrison DG, Griendling KK. Distinct roles of Nox1 and Nox4 in basal and angiotensin II-stimulated superoxide and hydrogen peroxide production. Free Radical Biol Med 2008;45: 1340-1351.
24. Yang H, Roberts LJ, Shi MJ, Zhou LC, Ballard BR, Richardson A et al. Retardation of atherosclerosis by overexpression of catalase or both Cu/Zn-superoxide dismutase and catalase in mice lacking apolipoprotein E. Circ Res 2004;95: 1075-1081.
25. Anilkumar N,Weber R, Zhang M, Brewer A, Shah AM. Nox4 and Nox2 NADPH oxidases mediate distinct cellular redox signaling responses to agonist stimulation. Arterioscler Thromb Vasc Biol 2008;28:1347-1354.
26. Daugherty A, Cassis L. Angiotensin II-mediated development of vascular diseases. Trends Cardiovasc Med 2004;14:117-120.
27. Pendyala S, Usatyuk PV, Gorshkova IA, Garcia JGN, Natarajan V. Regulation of NADPH oxidase in vascular endothelium: the role of phospholipases, protein kinases, and cytoskeletal proteins. Antioxid Redox Signal 2009;11:841-860.